Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
TSX Growth Companies With High Insider Ownership In February 2025

In This Article:

As we enter February 2025, the Canadian market has seen a modest 3% rise, navigating through stabilized yields and contained inflation rates. In this environment, growth companies with high insider ownership can be particularly appealing as they often indicate strong confidence from those closest to the business, providing a potential buffer against economic uncertainties.

Top 10 Growth Companies With High Insider Ownership In Canada

Name

Insider Ownership

Earnings Growth

Propel Holdings (TSX:PRL)

36.5%

38.7%

Vox Royalty (TSX:VOXR)

11.9%

83.3%

Robex Resources (TSXV:RBX)

25.4%

141.5%

Orla Mining (TSX:OLA)

11.5%

50.5%

Allied Gold (TSX:AAUC)

17.7%

76.9%

West Red Lake Gold Mines (TSXV:WRLG)

13.5%

77.6%

Aritzia (TSX:ATZ)

18.6%

45.1%

Enterprise Group (TSX:E)

32.2%

26.7%

Burcon NutraScience (TSX:BU)

12.8%

152.2%

CHAR Technologies (TSXV:YES)

10.8%

60.5%

Click here to see the full list of 37 stocks from our Fast Growing TSX Companies With High Insider Ownership screener.

Let's dive into some prime choices out of the screener.

Bombardier

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Bombardier Inc. is involved in the design, manufacture, and sale of business aircraft and aircraft structural components globally, with a market cap of approximately CA$8.72 billion.

Operations: The company's revenue is primarily derived from its Aviation segment, which generated $8.67 billion.

Insider Ownership: 11.8%

Bombardier's insider ownership and growth potential are under scrutiny. Despite its shares trading significantly below estimated fair value, recent earnings reveal challenges, with net income and profit margins declining compared to the previous year. While revenue growth is projected to lag behind the Canadian market, Bombardier's earnings are expected to grow substantially over the next three years. The company faces financial pressure as interest payments strain earnings coverage, yet it continues expanding service capabilities with strategic investments like the new paint facility at London Biggin Hill.

TSX:BBD.B Ownership Breakdown as at Feb 2025
TSX:BBD.B Ownership Breakdown as at Feb 2025

Knight Therapeutics

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Knight Therapeutics Inc. is a company that develops, manufactures, acquires, licenses, markets, and distributes pharmaceutical and consumer health products as well as medical devices globally; it has a market cap of CA$563.65 million.

Operations: The company generates revenue primarily from its Pharmaceuticals segment, which amounts to CA$348.64 million.